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ABSTRACT
With the rapid advancement of regenerative medicine technologies, there is an urgent
need for the development of new, cell-friendly techniques for obtaining nanofibers—
the raw material for an artificial extracellular matrix production. We investigated the
structure and properties of PCL10 nanofibers, PCL5/PCL10 core-shell type nanofibers,
as well as PCL5/PCLAg nanofibres prepared by electrospinning. For the production
of the fiber variants, a 5–10% solution of polycaprolactone (PCL) (Mw = 70,000–
90,000), dissolved in a mixture of formic acid and acetic acid at a ratio of 70:30
m/m was used. In order to obtain fibers containing PCLAg 1% of silver nanoparticles
was added. The electrospin was conducted using the above-described solutions at
the electrostatic field. The subsequent bio-analysis shows that synthesis of core-shell
nanofibers PCL5/PCL10, and the silver-doped variant nanofiber core shell PCL5/PCLAg,
by using organic acids as solvents, is a robust technique. Furthermore, the incorporation
of silver nanoparticles into PCL5/PCLAgmakes such nanofibers toxic tomodelmicrobes
without compromising its biocompatibility. Nanofibers obtained such way may then
be used in regenerative medicine, for the preparation of extracellular scaffolds: (i) for
controlled bone regeneration due to the long decay time of the PCL, (ii) as bioscaffolds
for generation of other types of artificial tissues, (iii) and as carriers of nanocapsules
for local drug delivery. Furthermore, the used solvents are significantly less toxic than
the solvents for polycaprolactone currently commonly used in electrospin, like for
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example chloroform (CHCl3), methanol (CH3OH), dimethylformamide (C3H7NO) or
tetrahydrofuran (C4H8O), hence the presented here electrospin technique may allow
for the production of multilayer nanofibres more suitable for the use in medical field.
Subjects Bioengineering, Biotechnology, Synthetic Biology
Keywords Policaprolacotne, Nanofibers, Solution electrospinnning, Core-shell nanofibers,
Co-axial electrospinning
INTRODUCTION
In simple terms, tissues are composed of cells and extracellular matrix (ECM). Rapid
development of regenerative medicine techniques has prompted the development of
technologies for the generation of given types of cells on demand, i.e., by reprogramming
with subsequent differentiation, or by transdifferentiation (Cieslar-Pobuda et al., 2016).
To complete the production of artificial tissues, one also needs ECM that would give
the cells proper support, and maintain appropriate stiffness/elasticity and strength of
the manufactured tissue-replacements. Beside natural compounds such as collagens,
proteoglycans and glycoproteins, artificial nanofibers become increasingly tested as
replacement-components of artificial extracellular matrices (O’Brien, 2011). Although
several types of nanofibers have been manufactured so far, none of them entered broadly
into clinical practice beside the experimental phase, mainly due to the biocompatibility
issues (Sperling et al., 2016).
The preparation ofmicro- and nanofibers under an electrostatic field could be performed
either by electrospin from the rawmaterial in solution (Fig. 1) or from the melted material.
The initial properties of the polymeric material will dictate what kind of method for the
preparation of the nanofibers will be chosen. For example, in case of natural polymers
like chitosan, which do not melt at higher temperature, electrospinning is chosen for
the preparation of micro- and nanofibers (Cai et al., 2010; Paneva et al., 2009). Melt
electrospinning is chosen for the generation of nanofibres which form thermoplastic
polymers such as polypropylene, which is difficult to dissolve but melts at higher
temperatures (Fang et al., 2012). Some polymeric materials could be converted into the
nanofiber using electrospinning of the solution and also melt-electrospinning. Examples
of these types of materials serve PVA, N6 (Brown et al., 2014), PMMA (Qian et al., 2010).
Electrospinning is the most common method for the preparation of nanofibres from
the solution. The properties of the nanofibers obtained in the process, like diameter of
fibers, surface morphology, and regularity of shape depend on three main conditions:
(i) environment (the temperature of gas in which electrospinning occurs, gas humidity,
gas flow velocity), (ii) process conditions (i.e., the type of electrodes used, the flow rate
of the solution, the distance between the electrodes, the rotational speed of the rotary
collector), and (iii) the properties of the dissolved material in solution, which is the
sum of the properties of the polymeric material, the properties of the solvent, and the
properties of introduced additives. Each of these three sets of conditions and properties
is directly or indirectly related to the others (Andrady, 2008). For example, the properties
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Figure 1 Diagram of the applied coaxial electrospinning process.
Full-size DOI: 10.7717/peerj.4125/fig-1
of the polymeric material will dictate the type of solvent, which is used to dissolve it
(Wang et al., 2010). Because most polymers are dielectrics, adding the solvent will decrease
the conductivity of the solution. However, there are polymeric materials, such as chitosan,
which when added to the solution, will increase the conductivity of the resulting solution.
Converting the polymer solution into nanofibres occurs due to the evaporation of the used
solvent.
A variation of the electrospinning process called coaxial-electrospinning was employed
in this paper (Fig. 1) (Zhang et al., 2010). Just like during the standard electrospinning
process, shortly after passing the nozzle, under optimal conditions, a Taylor cone is created
(double cone in coaxial electrospin). The shape and properties of Taylor cones depend
on the characteristics of the respected polymer-forming solutions. At the contact-zone
both solutions interact, and the nature of this interaction is formative for the coaxial
electrospinning process. The coating solution is stretched by a electrostatic field within the
zone of straight-forward flow (according to Faraday’s law, the charge accumulates on the
outer wall of a structure). The flow of the core-forming solution is also stretched due to the
interactions and friction imposed on it by the coating solution. The shaping (morphology)
of nanofibers of the core-shell polymer-type is also strongly influenced by the evaporation
rate of solvents used in the process. If the core-forming material is dissolved with a solvent
with a much higher evaporation rate than the solvent in the coating polymer, a thin layer
(wall) will form within the core that will cause the solvent to diffuse slowly. In effect, an
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under-pressure is created within the core, which will cause the collapse of the core, and
results in a strip/ribbon shape of the nanofibre.
Coaxial electrospinning technology is significantly more difficult than the single-
material electrospining; however, it enables the preparation of fibers having much broader
applications. For example, it allows for obtaining hollow fibers (Khajavi & Abbasipour,
2012; Kroczak et al., 2006; Srivastava et al., 2007), core–shell type fibers (Yu et al., 2012),
encapsulating other compounds and biologic materials (McCann, Marquez & Xia, 2006),
encapsulation of macromolecular materials such as i.e., DNA, preparation of composite
fibers (Xu et al., 2004), a combination of polymeric materials with different properties
(Zhang et al., 2010), or production of tissue scaffolding with a desired disintegration
time (Szabo et al., 2014). The purpose of the following study was to prepare core–shell
nanofibers using a combination of two organic acids as solvents for PCL. Organic acids
at trace-quantities are, in general, better tolerated by living tissues than organic solvents
commonly used for electrospinning.
MATERIALS AND METHODS
Materials
For the preparation of a biodegradable composite fiber we used PCL having a molecular
weight of Mw = 70,000–90,000; Sigma Aldrich, St. Louis, MO, USA. We used organic
solvents: formic acid (99.9% purity), and acetic acid (also 99.9% purity) purchased from
Sigma Aldrich (St. Louis, MO, USA). Silver nanoparticles with a diameter of 20–30 nm,
and the purity of 95.95% were from Skyspring Nanomaterials.
Dissolving the polymers
For the preparation of nanofibres applied:
(a) a mixture of formic acid and acetic acid in a ratio of 70:30 m/m was prepared, to which
the silver nanoparticles were introduced in an amount of 1%, while using a ultrasonic
homogenizer for 30 min. Next, to the solution PCL (Mw = 70,000–90,000) was added,
and dissolved, to give a 10% solution of PCLAg
(b) a mixture of formic acid and acetic acid in a ratio of 70:30 m/m was prepared, to
which the granules of PCL (Mw = 70,000–90,000) was added while stirring with the
magnetic stirrer, until the 10% solution of PCL was obtained (PCL10). Following a
similar approach, also the PCL5 solution was prepared
(c) using a similar approach, we also prepared PCL5 solution. The 70:30 mixture-ration for
both solvents was determined empirically as a good compromise of material solubility,
and evaporation ratio.
Electrospinning
The PCL5-, PCL10-, and PCL/Ag-solutions (prepared as described above) were used. For
the preparation of solid (one layer) nanofibres the PCL10 was used. The PCL10 solution
was combined with PCL5 solution to obtain a core–shell nanofibers PCL5/PCL10. PCL5
solution was combined with the PCL/Ag solution to prepare the PCL5/PCL/Ag nanofibres.
The electrospin-parameters were as follow: the flow range 0.05–1.5 ml/h, the voltage
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range 0.8–1.2 kV/cm, collector (negative electrode): SS Flat Plate (400 mm × 400 mm),
single nozzle injector (positive electrode) outer needle 0.9 mm, co-axial injector (positive
electrode) inner needle 0,6 mm, outer needle 1,4 mm, humidity: 32% ± 4%, temperature:
23 ◦C ± 2 ◦C. The electrospin was done using Coaxial Electrospinning & Electrospray 550
from Yflow.
Testing of the obtained nanofibers
FTIR
The evaluation of the structure of PCL was performed using FTIR infrared spectroscopy.
The technique is used to determine the presence of functional groups within PCL. For
visualization purpose, the sample was combined with KBr powder in a proportion 0.1 mg
of fibers to 3g KBr, compressed to form pellets and then placed in a desiccator with a
moisture binder (sillica gel) for 30 min at 40 ◦C. After drying, the samples were placed in
the autosampler of the device, and were scanned 128 times with a resolution of 4 cm−1 in
wavelength range between 400–4,000 cm−1.
XRD
X-ray diffraction techniques were used to determine the structure of silver nanoparticles in
PCL5/PCL/Ag nanofibres. The X-ray diffraction measurements for selected samples were
Performed at ambient temperature using a Rigaku MiniFlex 600 Diffractometer (Rigaku
Corporation, Tokyo, Japan) with Cu Kα radiation (λ= 1.5406 Å), at tube voltage of 40 kV
and a current of 15 mA using a D/teX Ultra silicon strip detector.
SEM & TEM
The topography of the obtained nanofibres were analyzed by using scanning electron
microscope Zeiss Supra at different settings of the acceleration voltage and magnification
ranges, selected for optimal observation of samples. Samples of the tested nanofibres (PCL10,
PCL5/PCL10, PCL5/PCLAg) were applied directly onto the surface of copper mesh and
subjected to structural analysis using a high resolution transmission electron microscope
TEM at an accelerating voltage of 300 kV and modes of the Fourier transformation FFT
inverse Fourier transformation IFFT, using a bright-field detector BF, a high resolution
wide angle dark field detector HAADF, STEM scan mode transmission, and a standard
EDS detector.
Cell viability tests
The biocompatibility (potential toxicity) of the generated nanofibres was assessed by
MTT assay using normal human dermal fibroblasts (NHDF) obtained from Professor
G. Kratz, (Cieslar-Pobuda et al., 2014), or from Clonetics (CC-2511; San Diego, CA, USA).
NHDF were used because they are common starting material for reprogramming or
transdifferentiation techniques, both commonly used for the production of desired cell
types for regenerative medicine purposes. The procedures were performed similarly as
described previously (Magnusson et al., 2015). The cells were cultured in DMEM-F12
(SIGMA) supplemented with 10% FBS fetal calf serum solution (SIGMA), in sterile and
standard conditions (37 ◦C, 60% humidity, 5% CO2), while being kept in logarythmic
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phase. For testing, cells were trypsinized, and plated on the test composites placed in 96-well
plates (final density suspend 2 × 104 cells/well). Following 72 h incubation, MTT-reagent
(3–(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Sigma-Aldrich) was
added at concentration 0.5 mg/ml. After further 4 h incubation, the MTT solution was
removed and the formazan product was dissolved in dimethyl sulfoxide. The absorbance
was measured at 550 nm with a VICTORTM X Series Multiple Plate Reader.
Confocal microscopy
Biological studies were conducted on cell line NHDF (Normal HumanDermal Fibroblasts).
The composite material with diameter equal to 2 cm was UV-sterilized and then it was
placed into a cell culture incubator. One each sample, a cell suspension volume of 200 µl
(∼2 × 105 cells) was applied, and then placed into incubator for 1,5 h at a temperature
of 37 ◦C. After 1.5 h in the incubator 3 ml of culture medium was added to each sample.
The samples were then incubated for 96 h at 37 ◦C. The tests were performed on three
samples, for each fiber type. In order to determine the cells presence and their adhesion
to the surface of the nanofibers the samples were removed from the incubators, after 96 h
of culture, then placed onto a glass slides and fixed with ethyl alcohol. After fixation the
samples were stained with 40 µg/ml of propidium iodide to visualize the DNA in the cells.
The excess of propidium iodide was removed by washing the samples with distilled water.
Later each sample surface was covered with glycerol and then covered with a coverslip. The
prepared samples were inspected by confocal microscopy (600 nm wavelength).
Evaluation of antimicrobial activity
Antimicrobial properties of prepared nanofibers were tested on standard microbial agents
S. aureus ATCC 25923, C. albicans ATCC 10231, and E. coli ATCC 25922. All tests were
performed in quadiplicates. Square (10 × 10 mm) plasma-sterilized samples of the tested
nanofibres were immersed in 4 ml of microbial solution 1.5 × 105 CFU/ml, incubated
for 17 h at 37 ◦C, under atmospheric oxygen. Then, 20 µl of medium samples from
each incubation were seeded on a solid growth support (Bacto-agar for the bacteria, or
Sabouraud-agar for C. albicans), and incubated for further 48 h at 37 ◦C. A total of 20 µl of
microbe-free medium samples were used as negative controls, whereas the same quantities
of microbial cultures, that were not in contact with the tested nanofibers, were used as
positive controls. After 48 h of incubation, the anti-fungal efficacy (AFE), or anti-bacterial
efficacy (ABE) were calculated according to the following formula:
AFE[] = Vc−Vt
Vc
100
where: Vc, microbial growth density by positive control; Vt, microbial growth density in
tested sample. The obtained data is presented in Table 1.
RESULTS
The PCL nanofibers obtained by electrospin from its 10% solution in a mixture of formic
acid and acetic acidwere analyzed by the spectrometer FTIR (Fig. 2). The analysis confirmed
the presence of: (i) stretching vibrations of C=O for the wave 1,720 cm−1, (ii) symmetrical
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Figure 2 The analysis of the obtained with our process PCL nanofiber. FTIR for polycaprolactone
nanofiber (A), XRD spectrum for nanofiber polycaprolactone (B), and EDS for silver nanoparticles (C).
Full-size DOI: 10.7717/peerj.4125/fig-2
Table 1 Antimicrobial efficacy (AME) against the Staphylococcus aureus, Escherichia coli, and Candida albicans.Medians of antimicrobial effi-
cacy (AME) against the Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922 and Candida albicans ATCC 10231 standard strains for the
PCL nanofibers with different concentrations of silver nanoparticles, and Kruskal–Wallis tests results (α= 0.05).
Material Antimicrobial efficacy (AME), %
Staphylococcus aureus
ATCC 25923 (p= 0.003)‡
Escherichia coli
ATCC 25922 (p= 0.012)‡
Candida albicans
ATCC 10231 (p= 0.016)‡
Median Min/Max Median Min/Max Median Min/Max
PCL0/PCL0 (p= 1)† 0 * 0 * 0 *
PCL0/PCLAG (p= 0.437)† 99.9 * 99.9 55/99.9 99.9 0/99.9
Notes.
† P-values refer to the differences of AME listed in rows (different standard strains for a particular material) and
‡refer to differences of AME listed in columns (diverse antimicrobial agent concentrations after standard strain).
*no changes in quadruplicate
#both were above 99.9 but less than 100.
stretching vibration of C-H2 of wave 2,866 cm−1, (iii) asymmetrical stretching vibration
C-H2 wave 2,943 cm−1, (iv) the stretching vibration of C-O and C-C for the wave 1,294
cm−1, and (v) the stretching vibration of C-O and C-C to wave 1,163 cm−1, characteristic
for PCL. Using scanning electron microscopy, SEM (Fig. 3A), and TEM transmission
electron microscopy (Fig. 4A) confirmed the presence of PCL nanofibers in the test
samples, and provided the valuable information about their morphology. The use of a
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Figure 3 Assessment of the electrospinned nanofibres. The structure of the polycaprolactone
nanofibers (no dopant added) (A). The structure of silver nanoparticles used as a dopant in some
coaxial fibres (B). Images taken using a scanning electron microscope (SEM).
Full-size DOI: 10.7717/peerj.4125/fig-3
combination of formic acid with good electrical conductivity and acetic acid with low
electrical conductivity in a proportion of 70:30 m/m as a starting PCL solvents, proved
to be a successful solution allowing for stabilization of the electrospinning process of
nanofibers. It also allowed for obtaining a core-shell nanofibers with the diameter of less
than 100 nm. (Fig. 4B, and Fig. 5A, Fig. 5B). The core and shell components are clearly
visible both due to differential density of the respective forming materials, and also due to
their different thickness. While the same material (PCL) was used for both the core and
the shell formation, its starting concentrations were different. The differences in initial
concentrations of used PCL solutions effected in different evaporation rates and effected
in the final differential density of formed core and shell.
SEM-based investigation of obtained nanofibers (Fig. 3B) made it possible to determine
the grain structure of the used silver nanoparticles. The presence of silver was also confirmed
by studies usingEDSdiffractometer (Fig. 5). The data showed the presence of the plane (200)
characteristic of silver. In order of further confirm the components of these nanoparticles
a high-resolution TEM image from the selected area of Fig. 6 was shown in figure 6IFFT
and 6FFT. The lattice fringe of 0.205 nm corresponds to the (200) plane of cubic silver.
PCL-ray diffraction studies (Fig. 2) enabled, in turn, to determine the occurrence of two
strong peaks 22 for 22 ◦C and 24 ◦C, which correspond to the reflexes (110) and (200)
typical for PCL.
Studies using TEM in bright-field (BF) mode, confirmed the presence of nanofibers
of solid-type PCL10 (Fig. 4A), coaxial nanofibers PCL5/PCL10 (Fig. 4B), and PCL5/PCLAg
(Fig. 5A TEM BF-mode and Fig. 5B TEM STEM-HAADF-mode).
PCL10 fibers, coaxial PCL5/PCL10-, and PCL5/PCLAg fibers, all are characterized by
regularity in diameter and lack of surface defects such as so-called beads. Hence, this shows
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Figure 4 Examples of the nanofibres generated by electrospin, as assessed by TEM. The structure
PCL10 nanofiber obtained with a standard electrostatic field electrospin (A). The core-shell PCL5/PCL10
nanofibers obtained with coaxial electrospinning (B). Photographs taken using a transmission electron
microscope (TEM).
Full-size DOI: 10.7717/peerj.4125/fig-4
Figure 5 Examples of silver-nanoparticle-doped nanofibres generated by electrospin. The structure of
the core-shell PCL5/PCLAg nanofibers observed in the TEM (BF mode) (A). The structure of the core-shell
PCL5/PCLAg nanofibers observed in TEM (HAADF-STEMmode) (B). Images of silver nanoparticles are
clearly visible in both pictures.
Full-size DOI: 10.7717/peerj.4125/fig-5
that the combination of solvents used, and the chosen molecular weight of the polymer,
allow for reliable production of nanofibers, through a very stable electrospinning process.
Using TEM, we estimated the diameter of the PCL10 nanofibers to be 98 ± 5 nm, the
diameter of the obtained coaxial filaments PCL5/PCL10 to be 93 ± 5 nm, whereas the
diameter of the silver-nanoparticle-doped coaxial nanofibers PCL5/PCLAg to be 86 ±
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Figure 6 The structure of silver nanoparticles used to generate the doped coaxial nanofibres.
Photographs were taken using a high resolution TEM in Fourier Transform mode (FFT), inverse Fourier
transform mode (IFFT), the BF mode, and HREMmode. See individual reflections silver FFT correspond
to the planes (200), i.e., the FFC silver nanostructres.
Full-size DOI: 10.7717/peerj.4125/fig-6
5 nm. Interestingly, we have observed the decrease in the diameter of the coaxial nanofiber
PCL5/PCL10 as compared to solid nanofibers PCL10, and a further decline in fiber diameter
for the silver-nanoparticle doped coaxial nanofibres PCL5/PCLAg as compared to coaxial
nanofibers PCL5/PCL10 that do not contain the silver nanoparticles.
The diameter of the core of our coaxial nanofiber PCL5/PCL10, is 15 ± 3 nm, and it
represents 17–19% of the total diameter of the fiber. Whereas for the silver-nanoparticle
doped nanofibres PCL5/PCLAg, the diameter is 12 ± 3 nm, thus representing 14–16%
of the total diameter of the fiber. Thus, the thinning of the silver-doped nanofibers was
mainly due to the thinner core produced by the electrospinning process. Importantly, in
both types of coaxial nanofibers, the cores occupy central part of the fiber. This shows that
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Figure 7 PCL5/PCL10 are nontoxic, and the support well growth of human cells. An example of cell
growth on PCL5/PCL10: confocal microscopy micrographt of NHDF cells stained with propidium iodide
(DNA) that were grown for 96 h on the nanofibers PCL5/PCL10 (A). The evaluation of NHDF cell sur-
vival by MTT assays (B).
Full-size DOI: 10.7717/peerj.4125/fig-7
the electrospinning produced high-quality nanofibers (the thickness of the coating evenly
distributed around the core).
The biocompatibility (potential cytotoxicity) of the produced coaxial nanofibers was
assessed using propidium iodide staining of cell nuclei and subsequent observation under
confocal microscopy (assessment of shrunken, brightly-stained, apoptotic nuclei, Fig. 7A),
and by MTT assay (detection of mitochondrial oxidation, Fig. 7B). The microscopic
assessment of cells stained with propidium iodide indicate that the frequency of dead
cells with condensed (brightly-stained) nuclei was below 10%, hence consistent with
naturally-occurring cell death in culture. The data show that both types of nanofibers
(PCL5/PCL10 and PCL5/PCLAg) exhibit good biocompatibility, as assessed using NHDF
cells. Surfaces of the tested coaxial nanofiber PCL5/PCL10 and PCL5/PCLAg are not toxic to
the cells and allow them for attachment and metabolic activity. While more advanced tests
are necessary, the preliminary data indicate that the structure of the obtained filaments
supports NHDF cell proliferation, thus these materials should be subjected to in vivo
assays to assess their potential use as a tissue scaffold replacements. The observed in
MTT-assay apparent increase of cell viability on nanofibers is likely due to the increased
surface area offered to the growth of tested fibroblasts. Since MTT-assay measures de facto
mitochondrial oxidative activity, the available increase of space likely allows for more
mitochondria per cell and in effect higher values in MTT-assay.
Finally, we have checked the antimicrobial potential of our nanofibers by using model
microbes Staphylococcus aureus strain ATCC25923, Escherichia coli strain ATCC25922, and
Candida albicans strain ATCC 10231. As shown in Table 1, in contrast to the PCL0/PCL0,
that as expected, were non-toxic to the testedmicroorganisms, the PCL0/PCLAG killedmost
of S. aureus, C. albicans, and E. coli. The presented data clearly underlines the antibacterial
activity of nano-silver incorporated into our PCL fibers.
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DISCUSSION
Hereby we describe the production and testing of electrospinned (coaxial) nanofibers; some
doped with Ag-nanoparticles. Instead of a highly toxic organic solvent normally applied,
a less toxic organic-acids were employed to dilute the polymers used for electrospin. Our
study describe how to obtain core-shell nanofibers in an electrostatic field with a 10%
solution of the polymer dissolved in a mixture of formic acid and acetic acid in a ratio of
70:30 m/m. Biomaterials which are produced to substitute natural tissue scaffolds should
meet certain criteria, among others, lack of toxicity, exhibit biocompatibility, sufficient
strength, the optimal porosity and surface available for cell adhesion (O’Brien, 2011).
Compliance with these criteria is a necessary condition for the biomaterial to functionally
restore the natural structure of the tissue.
The lack of toxicity of the electrospinned scaffolds depends on the properties of the
starting materials from which it was made, and also to the lesser degree, on the used
solvents (traces of solvents usually are difficult to be removed form the biomaterial), it also
depends on possible contaminants, i.e., metal ions that may be toxic (Hashemi et al., 2007).
The literature frequently describes DMF (dimethylformamide), THF (tetrahydrofuran),
chloroform, or methanol as solvents used for PCL tested in this work (Andrady, 2008;
Khajavi & Abbasipour, 2012). These organic solvents are highly toxic to cells, and their
residual amounts may leak from the implanted into the body biomaterial. This issue is
typically ignored by the authors when discussing biocompatibility, and lack of toxicity
of the electrospun biomaterials, mostly because such assessments are based either on
nanofiber extracts tested for cytotoxicity, and/or on a short in vitro study, typically lasting
a few days. Under such conditions the residual toxicity of the used organic solvents would
not be fully revealed. Such in vitro studies will unlikely reveal residual toxicity of organic
solvents, because the cells are in contact only with surface of the tested fibres, that usually
would be solvent-free (evaporated), and the tested material is immersed in large quantities
of cell medium which further minimizes solvents’ potential toxicity. Upon implantation,
the conditions differ, because as PCL degrades (complete degradation of PCL may take
up to two years) it releases the residual organic solvents. Hence, the in vitro studies are
unable unequivocally state whether the material throughout the period of degradation
would be a nontoxic to-, and biocompatible with the surrounding cells because trapped
in the structure solvents such as chloroform, DMF, or others, may be released during the
degradation of the polymer and could adversely affect the surrounding cells.
To avoid the prospective leakage of toxic organic solvents from the electrospun coaxial
nanofibers we have dissolved the PCL in a mixture of formic acid and acetic acid. As shown
in the Figs. 3A, and 4B the electrospinning process was very stable, and in all three types
of experiments it generated smooth nanofibers with a regular diameter. The electrostatic
field was responsible for the observed decrease in the coaxial fiber diameter PCL5/PCL10
as compared to the non-coaxial fiber PCL10. The electrostatic field was tuned the way
that it would stretch the coating solution and guarantee optimum friction for stretching
of the core. The observed further decrease in PCL5/PCLAg fiber diameter as compared to
PCL5/PCL10 fibers corresponds to the presence of silver. Metallic silver is more conductive
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to electrical charge than popular in the industry copper. Hence, the added silver that was
uniformly distributed in the solution by prior ultrasound-homogenization, increases the
conductivity of the solution. As shown by us, and by others (Chen & Schluesener, 2008;
Dallas, Sharma & Zboril, 2011), doping of nanofibers with silver nanoparticles offers an
additional advantage, namely it makes the nanofibers resistant to microbial colonization.
Graft infection is a fairly common problem in post-surgery care (Fujii & Watanabe, 2015;
Revest et al., 2015). Hence incorporation of silver nanoparticles into bioscaffolds not only
improves its electroconductivity but also diminishes the risk of infectious post-operative
complications.
Electric conductivity is responsible for stretching the fibers. As already discussed above,
the increase of conductivity of the mixture (polymer + solvents) will reduce the diameter
of the obtained nanofibers. This is due to the higher stretching of the fibers by the present
electrostatic forces. This was clearly revealed by our experimenys since doping of PCL with
nanosilver resulted in generation of thinner nanofibers. Viscosity of the electrospinning
solution has the opposite effect as electric conductivity. Higher viscosity results in the
higher diameter of electrospun fibers, because the electrostatic forces will be less effective
in stretching the formed nanofibers. Hence, the final result of the electrospining process
(either nanofibres or microfibers) is determined by competing forces in the solution caused
by electrostatic and viscosity properties.
The applied in our experiments mixture of the solvents is very well suited for biological
use as they have amuch lower toxicity, when compared to commonly-described in scientific
papers organic solvents such as THF, DFM, chloroform, or methanol. Both solvents that we
used could easily enter basic cellular metabolic pathways (Lecca, 2014). The FTIR studies
were conducted to determine structure and integrity of the obtained PCL fibers. The FTIR
was conducted using dry PCL fibers. FTIR studies have confirmed the presence and integrity
of PCL, hence, the used combination of solvents did not adversely affect the surface of
the obtained polymers. Lack of toxicity of the resulting tissue scaffold-replacement was
confirmed by the MTT assays. The prepared by us biomaterials could potentially be used in
surgery. The described newmaterials form a good substrate as experimental tissue scaffolds
for preparation of experimental artificial organs by using both induced-pluripotent stem
cells (iPS) and also transdifferentiation techniques (Cieslar-Pobuda et al., 2016; Cieslar-
Pobuda et al., 2015; Gelmi et al., 2016). Their coaxial structure allows for embedding in the
core medicinally-active substances. In vivo studies are necessary to further confirm the
biocompatibility of the prepared nano-biomaterials.
The development of biomaterial-based artificial tissues offers protection from an
accidental transfer of viral infections (marked risk in case of human- or animal-derived
donor tissues). Viruses may contribute to carcinogenesis; such as, for example, human
papillomaviruses (cervical and oral cancer) (Liu et al., 2016; Zaravinos, 2014), Human
T-cell Leukemia Virus (hairy cell leukemia) (Chlichlia et al., 2002; Los et al., 1998) and so
on. However, as with some other diseases (Likus et al., 2016c), it is sometimes difficult
to clearly associate the given pathogen with cancer etiology. On the other hand, many
viruses preferentially, or exclusively replicate in dividing cells; hence, their components
are potentially becoming an important source/inspiration in the search of drugs that
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preferentially target cancer stem cells (Akbari-Birgani et al., 2016; Farahani et al., 2014; Jain
et al., 2015; Jain et al., 2016). Beside viral methods, some clinically tested drugs as well as
new drugs with preferential toxicity towards cancer stem cells are increasingly becoming
available (Jangamreddy et al., 2013; Likus et al., 2016a; Likus et al., 2016b; Moghadam et al.,
2015; Moosavi et al., 2016). Such tasks are facilitated by recent progress in methodologies
that allows for better detection and monitoring of cancer stem cells (Cieslar-Pobuda et al.,
2016; Cieslar-Pobuda et al., 2015; Likus et al., 2016b).
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